Drawing for JP JAZZ PHARMACEUTICALS

USPTO serial 88223215

JP JAZZ PHARMACEUTICALS

Reviewed by CopyMark Law Group

Reg. 6077593Status 702Renewal
Filing date
Status date
Registration date
Jun 16, 2020
Examiner
LEE, JEANIE H
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with JP JAZZ PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael Olsen

Michael Olsen Winthrop & Weinstine, P.A.225 SOUTH 6TH STREET, SUITE 3500MINNEAPOLIS, MN 55402United States

Goods and services

ClassDescriptionStatusFirst use
044Medical information; providing medical information; providing pharmaceutical support services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and providing information relating to medicinal dosage for medical treatment purposes; providing healthcare information, medical information, and pharmaceutical support services in the nature of providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and safe and appropriate use and distribution of pharmaceuticals for medical treatment purposes; providing medical information relating to patient reimbursement for pharmaceuticals, namely, providing information and counseling regarding patient assistance programs to provide pharmaceuticals and medical treatment; providing medical information regarding patient access, namely, counseling services and information with respect to access to medical treatment, medical care, and pharmaceuticals, all via the Internet and by telephone and distribution of corresponding printed informational materials to patients, physicians, medical office staff, prescribers, and pharmaciesACTIVEAug 11, 2006

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 1, 2026NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Aug 10, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Aug 10, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Aug 10, 2026A7OKAMENDMENT UNDER SECTION 7 - PROCESSED—
Jul 27, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 23, 2026E815TEAS SECTION 8 & 15 RECEIVED—
Apr 23, 2026ES7RTEAS SECTION 7 REQUEST RECEIVED—
Nov 11, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 11, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 11, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 11, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 11, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 16, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 26, 2021ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jun 16, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 31, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 31, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 11, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 25, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 1, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 31, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 31, 2020ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 27, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 27, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 27, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 2, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 1, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 1, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 15, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 15, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 25, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 25, 2019COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 15, 2019CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED—
Mar 15, 2019ALIEASSIGNED TO LIE—
Mar 14, 2019GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Mar 14, 2019GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Mar 14, 2019CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Mar 7, 2019DOCKASSIGNED TO EXAMINER—
Jan 3, 2019MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jan 2, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 13, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance